These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


139 related items for PubMed ID: 2612862

  • 1. [Blood rheologic disorders in patients with polycythemia vera and their correction by therapeutic erythrocytapheresis].
    Likhovetskaia ZM, Prigozhina TA, Gorbunova NA, Kalinin NN, Petrov MM.
    Gematol Transfuziol; 1989 Nov; 34(11):33-6. PubMed ID: 2612862
    [Abstract] [Full Text] [Related]

  • 2. [Rheologic properties of the erythrocytes and hemostatic system in patients with polycythemia vera].
    Bessmel'tsev SS, Fedorova ZD, Abdulkadyrov KM.
    Gematol Transfuziol; 1989 Nov; 34(11):29-33. PubMed ID: 2612861
    [Abstract] [Full Text] [Related]

  • 3. [Changes in the rheologic properties of erythrocytes in various hematologic diseases].
    Fedorova ZD, Abdulkadyrov KM, Bessmel'tsev SS, Kotovshchikova MA.
    Gematol Transfuziol; 1989 Feb; 34(2):12-7. PubMed ID: 2707559
    [Abstract] [Full Text] [Related]

  • 4. Evaluation of hemostatic balance in blood from patients with polycythemia vera by means of thromboelastography: the effect of isovolemic erythrocytapheresis.
    Rusak T, Ciborowski M, Uchimiak-Owieczko A, Piszcz J, Radziwon P, Tomasiak M.
    Platelets; 2012 Feb; 23(6):455-62. PubMed ID: 22098131
    [Abstract] [Full Text] [Related]

  • 5. The hypercoagulability of polycythemia vera.
    Fields W, Freeman NJ.
    Hosp Pract (Off Ed); 1993 Sep 30; 28(9A):65-8, 72-3. PubMed ID: 8408361
    [Abstract] [Full Text] [Related]

  • 6. [Erythrocytapheresis in the complex treatment of polycythemia vera].
    Kovaleva LG, Melikian AL, Kho PI, Sedova GT, Petrov MM.
    Gematol Transfuziol; 1987 Nov 30; 32(11):10-4. PubMed ID: 3428540
    [No Abstract] [Full Text] [Related]

  • 7. [Effect of erythrocytapheresis on the oxygen-transport function of the blood in patients with polycythemia vera].
    Vinogradova IL, Bagriantseva SIu, Melikian AL, Kovaleva LG, Skachilova NN.
    Gematol Transfuziol; 1986 Jan 30; 31(1):42-4. PubMed ID: 3956970
    [No Abstract] [Full Text] [Related]

  • 8. [Erythron in patients with polycythemia vera during treatment by erythrocytapheresis and bloodletting].
    Gudim VI, Sarycheva TG, Kotel'nikov VM, Melikian AL, Ivanova VS.
    Ter Arkh; 1987 Jan 30; 59(6):48-51. PubMed ID: 3629498
    [Abstract] [Full Text] [Related]

  • 9. Hyperviscosity in polycythemia vera and other red cell abnormalities.
    Kwaan HC, Wang J.
    Semin Thromb Hemost; 2003 Oct 30; 29(5):451-8. PubMed ID: 14631544
    [Abstract] [Full Text] [Related]

  • 10. Hemorheologic considerations in the pathogenesis of vascular occlusive events in polycythemia vera.
    Pearson TC.
    Semin Thromb Hemost; 1997 Oct 30; 23(5):433-9. PubMed ID: 9387202
    [Abstract] [Full Text] [Related]

  • 11. Treatment of polycythemia vera by isovolemic large-volume erythrocytapheresis.
    Kaboth U, Rumpf KW, Lipp T, Bigge J, Nauck M, Beyer JH, Seyde W, Kaboth W.
    Klin Wochenschr; 1990 Jan 04; 68(1):18-25. PubMed ID: 2308267
    [Abstract] [Full Text] [Related]

  • 12. Platelet-related fibrinolysis resistance in patients suffering from PV. Impact of clot retraction and isovolemic erythrocytapheresis.
    Rusak T, Piszcz J, Misztal T, Brańska-Januszewska J, Tomasiak M.
    Thromb Res; 2014 Jul 04; 134(1):192-8. PubMed ID: 24824295
    [Abstract] [Full Text] [Related]

  • 13. Survey on the usage of therapeutic erythrocytapheresis in transfusion services in Italy for the treatment of polycythemia vera, secondary erythrocytosis and hemochromatosis.
    Iuliani O, Passeri C, Inghilleri G, Di Bartolomeo E, Abbruzzese L, Bianco I, Foddai ML, Natale GA, De Fusco G, D'Onofrio M, Fadda MG, Dominijanni A, Savignano C, Ostuni A.
    Transfus Apher Sci; 2023 Oct 04; 62(5):103752. PubMed ID: 37355441
    [Abstract] [Full Text] [Related]

  • 14. [Correction of disorders in the rheological properties of the blood in polycythemia vera patients using polidez].
    Mikhaĭlova LG, Shcherbakova EG, Kotovshchikova MA, Abdulkadyrov KM, Rozanova LM.
    Gematol Transfuziol; 1986 Jun 04; 31(6):9-12. PubMed ID: 3732784
    [No Abstract] [Full Text] [Related]

  • 15. [Physiological methods of treatment of patients with polycythemia vera].
    Neustroev GV.
    Ter Arkh; 1985 Jun 04; 57(7):54-9. PubMed ID: 2931850
    [Abstract] [Full Text] [Related]

  • 16. Red Blood Cell Morphodynamics in Patients with Polycythemia Vera and Stroke.
    Kuznetsova PI, Raskurazhev AA, Shabalina AA, Melikhyan AL, Subortseva IN, Tanashyan MM.
    Int J Mol Sci; 2022 Feb 17; 23(4):. PubMed ID: 35216363
    [Abstract] [Full Text] [Related]

  • 17. Cerebral Hemorrhage of a 50-Year-Old Female Patient with Polycythemia Vera.
    Chen L, Xiao H, Hu Z.
    J Stroke Cerebrovasc Dis; 2019 Aug 17; 28(8):e110-e112. PubMed ID: 31126786
    [Abstract] [Full Text] [Related]

  • 18. Failure of pentoxifylline or cilostazol to improve blood and plasma viscosity, fibrinogen, and erythrocyte deformability in claudication.
    Dawson DL, Zheng Q, Worthy SA, Charles B, Bradley DV.
    Angiology; 2002 Aug 17; 53(5):509-20. PubMed ID: 12365857
    [Abstract] [Full Text] [Related]

  • 19. [Effectiveness of intensive erythrocytapheresis in polycythemia vera].
    Kovaleva LG, Skachilova NN, Sedova GT, Kalinin NN, Krasiukova LI.
    Gematol Transfuziol; 1983 Oct 17; 28(10):17-20. PubMed ID: 6654006
    [No Abstract] [Full Text] [Related]

  • 20. [The rheologic aspects of washed donor erythrocytes].
    Ganapiev AA, Moiseev SI, Osipov VK, Shatrov VA.
    Gematol Transfuziol; 1989 Dec 17; 34(12):7-9. PubMed ID: 2628155
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.